Follow
CAR-T cell therapy
Chimeric antigen receptor (CAR) T cell therapy is a form of T cell engineering where T cells are obtained from a patient and engineered in a laboratory to better kill the patient's cancer cells. Specifically, CAR T cells are modified to express a receptor on their surface that recognizes the specific antigen present on the patient's cancer cells.
OCT 19, 2022 | 1:30 PM
COVID-19 remains a global health emergency with limited treatment options, lagging vaccine rates, and inadequate healthcare resources in the face of an ongoing calamity. The disease is chara...
OCT 19, 2022 | 10:00 AM
Date: October 19, 2022 Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST) In this webinar, we will introduce the generation and applications of Biocytogen’s severely immunodeficient (B-N...
OCT 19, 2022 | 9:00 AM
Date: October 19, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Stem cell therapy, in which stem cells are used for disease treatment or tissue repair, is an increasingly active area...
OCT 12, 2022 | 8:30 PM
Date: October 12, 2022, October 13, 2022 Time: 8:30pm (PDT), 11:30pm (EDT), 5:30am (CEST) High dimensional full spectrum flow cytometry holds the promise of addressing long-held questions in...
SEP 21, 2022 | 10:00 AM
Date: September 21, 2022 Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST) This talk aims to describe a popular workflow that profiles specific brain cell types in healthy and diseased post-m...
SEP 14, 2022 | 8:00 AM
Date: September 14, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) In this session, the benefits of combining in-line high speed imaging with flow cytometry will be explored. Acoustic...
JUL 21, 2022 | 8:00 AM
Date: December 09, 2022 Time: 11:00am (PST), 2:00pm (EST), 8:00pm (CEST) Flow cytometry is a trusted method to monitor T cell phenotype, plasticity, and functionality in basic research as we...
JUN 28, 2022 | 8:00 AM
Date: June 28, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) Developing safe and effective CAR T cell therapies is a challenging task. That’s why thinking translational early i...
MAY 31, 2022 | 9:00 AM
Date: May 31, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Introducing Nanostring’s latest spatial platform, CosMx Spatial Molecular Imager (SMI). Offering high-plex, multiomi...
MAY 24, 2022 | 9:00 AM
Date: May 24, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Recent breakthroughs in autologous cellular therapies have generated tremendous excitement for the industry; however, thes...
APR 21, 2022 | 5:30 AM
A hypoxic tumour microenvironment is a feature of solid tumours. Many tumour types contain high fractions of hypoxic tissue. The relationship between high levels of tumour hypoxia and a poor...
APR 20, 2022 | 7:30 AM
The COVID-19 pandemic has taken a dramatic toll worldwide. Its impact possibly has been the most palpable amongst uniquely vulnerable groups of patients, such as patients with a cancer diagn...
MAR 24, 2022 | 8:00 AM
Date: March 24, 2021 Time: 08:00am (PDT), 11:00pm (EDT) Simply enough, we want to treat our cells well. Afterall, we want them to tell us their stories in basic research or work for us in th...
DEC 09, 2021 | 8:00 AM
Date: December 9, 2021 Time: 8:00am (PDT), 11:00am (EDT) Engineering human regulatory T cells (Tregs) with a chimeric antigen receptor (CAR) targeting donorderived human leukocyte antigen (H...
DEC 08, 2021 | 8:00 AM
Date: December 08, 2021 Time: 8:00am (PDT), 11:00am (EDT) Learn how enrichment of primary dendritic cell (DC) subsets and sustainable DC manufacturing advances DC-based cell therapies. In th...
DEC 02, 2021 | 8:00 AM
Date: December 2, 2021 Time: 8:00am (PDT), 11:00am (EDT) Effective immunotherapy of pancreatic ductal adenocarcinoma (PDAC) is hampered by the lack of suitable tumor-specific antigens. To ad...
NOV 30, 2021 | 8:00 AM
Date: November 30, 2021 Time: 8:00am (PDT), 11:00am (EDT) The DNA Vector Lab at the German Cancer Research Center (DKFZ) has developed Nano-S/MARt (nS/MARt), a novel DNA Vector platform that...
NOV 18, 2021 | 8:00 AM
Date: November 18, 2021 Time: 8:00am (PDT), 11:00am (EDT) Keep ahead in CAR T and CAR NK cell research. We introduce advanced techniques for generating and characterizing engineered immune c...
NOV 16, 2021 | 8:00 AM
Date: November 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) The unique suppressive function of regulatory T cells (Treg cells) makes them an interesting target cell population to study. In rec...
NOV 03, 2021 | 7:00 AM
Date: November 3, 2021 Time: 7:00am (PDT), 10:00am (EDT) The reconstitution of a fully functional human immune system in mouse after engraftment of purified hCD34+ hematopoietic cells provid...
APR 20, 2022 | 7:30 AM
The COVID-19 pandemic has taken a dramatic toll worldwide. Its impact possibly has been the most palpable amongst uniquely vulnerable groups of patients, such as patients with a cancer diagn...
MAR 24, 2022 | 8:00 AM
Date: March 24, 2021 Time: 08:00am (PDT), 11:00pm (EDT) Simply enough, we want to treat our cells well. Afterall, we want them to tell us their stories in basic research or work for us in th...
DEC 09, 2021 | 8:00 AM
Date: December 9, 2021 Time: 8:00am (PDT), 11:00am (EDT) Engineering human regulatory T cells (Tregs) with a chimeric antigen receptor (CAR) targeting donorderived human leukocyte antigen (H...
DEC 08, 2021 | 8:00 AM
Date: December 08, 2021 Time: 8:00am (PDT), 11:00am (EDT) Learn how enrichment of primary dendritic cell (DC) subsets and sustainable DC manufacturing advances DC-based cell therapies. In th...
DEC 02, 2021 | 8:00 AM
Date: December 2, 2021 Time: 8:00am (PDT), 11:00am (EDT) Effective immunotherapy of pancreatic ductal adenocarcinoma (PDAC) is hampered by the lack of suitable tumor-specific antigens. To ad...
NOV 30, 2021 | 8:00 AM
Date: November 30, 2021 Time: 8:00am (PDT), 11:00am (EDT) The DNA Vector Lab at the German Cancer Research Center (DKFZ) has developed Nano-S/MARt (nS/MARt), a novel DNA Vector platform that...
NOV 18, 2021 | 8:00 AM
Date: November 18, 2021 Time: 8:00am (PDT), 11:00am (EDT) Keep ahead in CAR T and CAR NK cell research. We introduce advanced techniques for generating and characterizing engineered immune c...
NOV 16, 2021 | 8:00 AM
Date: November 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) The unique suppressive function of regulatory T cells (Treg cells) makes them an interesting target cell population to study. In rec...
NOV 03, 2021 | 7:00 AM
Date: November 3, 2021 Time: 7:00am (PDT), 10:00am (EDT) The reconstitution of a fully functional human immune system in mouse after engraftment of purified hCD34+ hematopoietic cells provid...